In the future, the downstream pathways related cell proliferation, apoptosis or kinases of TOPK would be worthy of further study, and the clinical value of TOPK in ALK-positive NSCLC must be further clarified. The gene discussed is PBK; the disease is non-small cell lung carcinoma.